Literature DB >> 11416623

Hypertension as a Risk for Erectile Dysfunction: Implications for Sildenafil Use.

Robert A. Kloner1.   

Abstract

Hypertension is one of several risk factors for erectile dysfunction. Others include the cardiovascular risk factors of low levels of high density lipoprotein, high total cholesterol, smoking, and diabetes. Certain antihypertensive drugs, especially the thiazide diuretics, can contribute to erectile dysfunction. Sildenafil is the first oral agent available for the treatment of erectile dysfunction. It works in patients with psychogenic as well as organic erectile dysfunction, including men with hypertension and men on antihypertensive medicines. Sildenafil alone causes small drops in systolic and diastolic blood pressure. When administered to patients on antihypertensive drugs it was again associated with small drops in arterial pressure and no increase in adverse events compared to patients not taking antihypertensive drugs. When sildenafil is given in the setting of organic nitrates (nitric oxide donors), large falls in blood pressure may occur. Sildenafil is absolutely contraindicated in the setting of organic nitrate use. (c)2000 by Le Jacq Communications, Inc.

Entities:  

Year:  2000        PMID: 11416623

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  4 in total

1.  A prospective study of the effect of antihypertensive medications on the sexual functions of hypertensive adult male patients.

Authors:  Akinwumi Akinyinka Akinyede; Obiyo Nwaiwu; Olumuyiwa John Fasipe; Adedunni Olusanya; Sunday Olufemi Olayemi; Bisola Akande
Journal:  Future Sci OA       Date:  2020-06-02

2.  Sildenafil citrate does not affect QT intervals and QT dispersion: an important observation for drug safety.

Authors:  Mete Alpaslan; Ersel Onrat; Murat Samli; Cetin Dincel
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

3.  Prevalence of sexual activity and associated factors in hypertensive males and females in China: a cross-sectional study.

Authors:  Xiaojun Chen; Qingying Zhang; Xuerui Tan
Journal:  BMC Public Health       Date:  2012-05-18       Impact factor: 3.295

Review 4.  Sexual function in hypertensive patients receiving treatment.

Authors:  Thorsten Reffelmann; Robert A Kloner
Journal:  Vasc Health Risk Manag       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.